Repressive effects of LSD 1 inhibitor pargyline on cellular proliferation , motility and EMT process of prostate cancer in vitro

Lu Zhang,Xiuheng Liu,Min Wang,Lei Wang,Hui Chen,Jia Guo,Xiaodong Weng
2018-01-01
Abstract:Objective: To elucidate the effect of lysine-specific demethylase 1 (LSD1) inhibitor pargyline on cellular proliferation, migration and the process of epithelial-mesenchymal-transition (EMT) in human prostate cancer in vitro. Methods: The roles of LSD1 inhibitor pargyline in cellular proliferation in prostate cancer cells in vitro were evaluated by CCK8, colony formation assay, and flow cytometry. Wound healing and transwell assay were used to evaluate the motility ability. Then β-actin and core genes of EMT (E-cadherin, N-cadherin, and Vimentin) were measured by western blotting and RT-qPCR to demonstrate the effects on EMT process. Clinical data was obtained from the online data sites (GEO, STRING). Results: Compared with the control group, treatment with pargyline inhibited the cell viability and proliferation of DU145 and PC-3 cells. Treated with 3 mM pargyline for 48 h, the cell apoptosis significantly increased and the cell cycle was arrested. For cellular motility, the wound closure was delayed and the passed cells in transwell migration assay decreased. In addition, the process of EMT was blocked, resulting in up-regulated expression of E-cadherin and down-regulated N-cadherin and Vimentin in both cell lines. Conclusions: LSD1 inhibitor alleviated the proliferation, migration, and EMT process in human androgen-independent prostate cancer in vitro.
What problem does this paper attempt to address?